Corticosteroids can contribute to acid reflux, and the evidence is more than anecdotal. A controlled study of asthma patients found that a short course of oral prednisone roughly doubled the time their esophagus was exposed to acid compared to placebo. But the relationship is messier than a simple cause-and-effect chain, because how much trouble steroids cause your esophagus depends on the type of steroid, the dose, the route of delivery, and especially what other medications you’re taking alongside them.
What Oral Corticosteroids Do to Esophageal Acid Exposure
The most direct evidence comes from a study that gave stable asthma patients either prednisone or a placebo for one week and then measured acid levels in their esophagus with a pH probe. During the prednisone phase, the percentage of time acid sat in the lower esophagus more than doubled, from about 2.5% on placebo to nearly 6% on prednisone. The effect was even more pronounced higher up in the esophagus, where acid exposure went from 0.3% to 0.8% of total time.1PubMed. Oral corticosteroids increase esophageal acid contact times in patients with stable asthma Those numbers sound small in absolute terms, but the clinical threshold for abnormal acid reflux is typically around 4-5% at the lower probe, so prednisone pushed these patients from normal territory into reflux territory.
What’s interesting is that this study did not find corresponding changes in esophageal sphincter pressure, gastric acid production, or reflux symptoms that patients reported. In other words, the esophagus was getting bathed in more acid, but the patients didn’t always feel it during the one-week trial. A separate study measuring manometrics and gastric acid secretion in asthma patients on prednisone likewise found no significant changes in those specific measures.2CHEST. Effect of Prednisone on Gastroesophageal Reflux in Asthma This creates a somewhat paradoxical picture: steroids increase measurable acid contact without clearly changing the usual mechanical suspects like sphincter tone or acid output.
Delayed Gastric Emptying as a Contributing Factor
One plausible explanation for why steroids worsen reflux without obviously weakening the esophageal sphincter is their effect on gut motility. When food sits in the stomach longer than it should, there’s more opportunity for acid to wash back up into the esophagus. An animal study found that prednisolone significantly delayed gastric emptying, stretching the half-emptying time from about 137 minutes to 184 minutes. A prokinetic drug (mosapride) reversed most of that delay.3Journal of Veterinary Medical Science. Effect of Mosapride on Prednisolone-Induced Gastric Mucosal Injury and Gastric-Emptying Disorder in Dog While this was an animal study, the finding fits with what many patients report: a heavy, bloated feeling in the stomach during a steroid course, with reflux symptoms following.
Slowed gastric emptying also means the stomach stays distended for longer after meals, which increases pressure on the lower esophageal sphincter. Even if the sphincter itself isn’t weaker, a stomach that empties sluggishly is more likely to push its contents upward. If you’re taking corticosteroids and noticing reflux mostly after eating, this delayed emptying mechanism may be a bigger part of the story than excess acid production.
Who Is Most at Risk
Not everyone on steroids gets reflux, and a real-world analysis of nearly 1,000 hospital inpatients on glucocorticoid therapy helps clarify who is most vulnerable. About 9% of those patients developed gastrointestinal complications, and nearly a third of those complications were acid regurgitation and heartburn. The analysis identified several independent risk factors that made GI problems more likely during steroid treatment:4PubMed Central. Risk factors for gastrointestinal complications during glucocorticoid therapy in internal medicine inpatients: a real-world retrospective analysis
- Age 65 or older: roughly double the odds of GI complications compared to younger patients.
- Existing GERD history: about 1.8 times the odds, which makes intuitive sense since steroids are aggravating a system that’s already compromised.
- History of peptic ulcers: over five times the odds, making this the single strongest predictor.
- Higher maximum steroid dose: a small but statistically real increase in risk per milligram.
- Concurrent NSAID use: nearly three times the odds, a factor important enough to deserve its own discussion.
If you’re a younger adult with no GI history, taking a moderate dose of prednisone for a week or two, your risk of troublesome reflux is real but relatively low. If you’re over 65 with a history of heartburn and also taking ibuprofen, the math changes considerably.
The NSAID Combination Problem
Corticosteroids and nonsteroidal anti-inflammatory drugs are frequently prescribed together, especially for inflammatory conditions like rheumatoid arthritis or severe flare-ups where pain control matters. But the combination is harder on the upper GI tract than either drug alone, and the effect isn’t just additive; it’s synergistic. A large epidemiological study found that combining steroids with high-dose NSAIDs produced roughly a 13-fold increase in risk of upper GI complications compared to using neither drug.5American Journal of Epidemiology. Steroids and Risk of Upper Gastrointestinal Complications Even with low-to-moderate NSAID doses, the combined risk was about four times higher than baseline.
A separate register-based study confirmed the pattern, finding about a threefold increased risk of hospitalization for upper GI bleeding during corticosteroid use, with the risk climbing further when steroids were combined with aspirin or other NSAIDs.6The American Journal of Medicine. Risk of hospitalization resulting from upper gastrointestinal bleeding among patients taking corticosteroids: a register-based cohort study This matters because many people on steroids reach for over-the-counter ibuprofen or naproxen without realizing they’re multiplying their GI risk. If you’re on a corticosteroid course, acetaminophen (Tylenol) is a much safer choice for routine pain relief.
Do You Need a Stomach-Protecting Drug With Steroids?
One of the most common questions patients have is whether they should automatically be prescribed a proton pump inhibitor (PPI) like omeprazole when they start steroids. The answer, according to a position paper on PPI therapy, is that steroid use alone does not require gastroprotection unless the patient is also taking NSAIDs.7PubMed Central. Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppression This is a somewhat surprising recommendation given how commonly PPIs are co-prescribed with steroids, and it reflects the fact that steroids alone are a relatively modest GI risk compared to NSAIDs.
That said, this guidance applies to average-risk patients. If you already have GERD, a history of ulcers, or you’re taking NSAIDs at the same time, the calculus shifts and prophylactic acid suppression makes more sense. Talk to your prescriber rather than just adding a PPI on your own, because long-term PPI use carries its own set of concerns. For short steroid courses with bothersome but not dangerous reflux, simple lifestyle measures like eating smaller meals, staying upright after eating, and avoiding late-night snacking can make a meaningful difference.
Inhaled Steroids Are Not Off the Hook
People often assume that inhaled corticosteroids, because they’re delivered directly to the lungs, won’t affect the GI tract. That’s mostly true, but not entirely. A study of over 18,000 patients found that those prescribed inhaled corticosteroids alongside albuterol had about a 26% higher risk of adverse gastrointestinal events compared to patients using albuterol alone.8PubMed Central. Risk of Adverse Gastrointestinal Events from Inhaled Corticosteroids The absolute numbers were still small: about 6.4% versus 2.5%. But the finding makes physiological sense, since a portion of every inhaled dose gets swallowed rather than deposited in the airways.
Here’s the practical takeaway: using a spacer device with your inhaler dramatically cut the GI risk, reducing it by about 74%. A spacer helps more of the medication reach the lungs and less of it end up in your throat and stomach. If you’re using an inhaled corticosteroid and experiencing heartburn or stomach discomfort, adding a spacer device is a simple first step before considering any additional medications.
High-Dose Pulse Therapy and Heartburn
Patients receiving high-dose intravenous or oral pulse steroids for conditions like multiple sclerosis or rheumatic disease often experience a cluster of side effects within 24 to 48 hours. In one study of patients treated with high-dose intermittent intravenous methylprednisolone, 38% reported a syndrome that typically included insomnia, restlessness, heartburn, flushing, and sweating. The heartburn was never severe enough to stop treatment, but it was common enough that patients should expect it.9JAMA Neurology. Treatment of Chronic Inflammatory Demyelinating Polyneuropathy With High-Dose Intermittent Intravenous Methylprednisolone
A separate study comparing high-dose oral prednisone to intravenous methylprednisolone found that both routes increased gastric permeability, meaning the stomach lining became somewhat leakier. About a quarter to 40% of patients in both groups showed modestly abnormal permeability afterward, with no significant difference between routes.10PubMed. Gastric tolerance of high-dose pulse oral prednisone in multiple sclerosis So switching from IV to oral pulse therapy doesn’t spare the stomach. A chart review of patients on high-dose IV pulse methylprednisolone for rheumatic diseases also documented gastric erosions among the complications requiring medical attention, though these were uncommon.11PubMed. A study of adverse effects of high-dose intravenous (pulse) methylprednisolone therapy in patients with rheumatic disease
When Steroids Actually Treat Esophageal Problems
Here’s where the story gets counterintuitive. While systemic corticosteroids can provoke reflux, topical steroids swallowed in a formulation designed to coat the esophagus are actually a frontline treatment for eosinophilic esophagitis (EoE), a condition where the esophagus becomes inflamed with a specific type of white blood cell. EoE causes difficulty swallowing, food impaction, and chest pain. Esophagus-targeted formulations of topical steroids, particularly budesonide, have achieved remission rates up to 85%, and an orodispersible budesonide tablet was approved as the first labeled medication for EoE in Europe in 2018.12PubMed Central. Treatment of eosinophlic esophagitis with swallowed topical corticosteroids
A Cochrane systematic review comparing topical fluticasone to oral prednisone for EoE found that both were similarly effective at resolving symptoms. Most participants were symptom-free at four weeks regardless of which steroid they received. However, 40% of those on oral prednisone experienced adverse effects including significant weight gain and cushingoid features, while topical fluticasone’s main downside was esophageal candidiasis (a yeast infection) in about 15% of patients.13PubMed Central. Non-surgical interventions for eosinophilic oesophagitis The tradeoff strongly favors the topical route for this particular condition. One important caveat: about 45% of patients relapsed within six months of stopping steroid therapy, regardless of which type they received. A 10-year review of children with EoE similarly found that steroids improved symptoms and esophageal histology, but both deteriorated after withdrawal.14PubMed. Eosinophilic esophagitis: a 10-year experience in 381 children
So the same class of drug that worsens acid reflux in one context treats a different esophageal condition in another. If you’ve been told you have EoE and prescribed a swallowed steroid, that’s an entirely different situation from the systemic steroid-reflux connection discussed above.
Anabolic Steroids and the Stomach
The conversation so far has been about corticosteroids, the anti-inflammatory kind prescribed for asthma, autoimmune diseases, and allergic reactions. Anabolic-androgenic steroids, the kind used to build muscle, are a different pharmacological category, but they’re not harmless to the GI tract either. A published case report described a 26-year-old bodybuilder who developed hemorrhagic gastritis (bleeding inflammation of the stomach lining) as part of multi-organ dysfunction after a course of anabolic steroids.15Thieme Connect / International Journal of Sports Medicine. Multi-organ dysfunction in bodybuilding possibly caused by prolonged hypercalcemia due to multi-substance abuse: case report and review of literature That’s an extreme outcome tied to multi-substance abuse rather than a typical side effect, but it’s a reminder that anabolic steroids are not benign for the digestive system. Reports of heartburn, nausea, and stomach irritation are common among anabolic steroid users, though rigorous controlled studies are rare because these drugs are typically used illicitly and in combinations that make it difficult to attribute effects to any single compound.
Distinguishing Steroid Reflux From Other Esophageal Problems
If you develop heartburn or difficulty swallowing while on corticosteroids, it’s worth knowing that not all esophageal discomfort during steroid treatment is classic acid reflux. Corticosteroids suppress the immune system, and that immunosuppression can open the door to infectious esophagitis caused by organisms like Candida (yeast) or herpes simplex virus. These infections cause chest pain and painful swallowing more often than the typical burning sensation of reflux. The distinction matters because infectious esophagitis needs antifungal or antiviral treatment, not just acid suppression.16PubMed Central. Esophagitis and its causes: Who is “guilty” when acid is found “not guilty”? If your symptoms are more “sharp pain when swallowing” than “burning behind the breastbone after meals,” or if heartburn doesn’t improve with antacids, your doctor may want to investigate beyond simple reflux.
Steroid Treatment and the Esophageal Microbiome
An emerging area of research involves how different treatments, including steroids, affect the microbial communities living in the esophagus. A study examining the esophageal microbiome in patients with eosinophilic esophagitis found that treatment with swallowed topical corticosteroids shifted the bacterial composition, lowering the proportion of Firmicutes and increasing Proteobacteria, Bacteroidetes, and Fusobacteria. The post-steroid microbiome ended up looking more similar to that of healthy controls than did the microbiomes of patients treated with PPIs or elimination diets.17Nature. Esophageal microbiome in active eosinophilic esophagitis and changes induced by different therapies This is still early-stage science, and the clinical relevance of these microbial shifts isn’t clear yet. But it suggests that the effects of steroids on the esophagus go beyond simple acid exposure and may involve changes to the local microbial ecosystem that could influence inflammation and symptoms in ways we don’t fully understand.